Cisen Pharmaceutical Co., Ltd. (603367.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In CNY
| Market Cap | 7.84B |
| Enterprise Value | 7.03B |
| P/E Ratio | 14.49 |
| PEG Ratio | -0.88 |
| Price/Sales Ratio | 1.76 |
| Price/Book Ratio | 0.94 |
| Enterprise/Revenue | 1.58 |
| Enterprise/EBITDA | 11.07 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.12 |
| Operating Margin | 0.12 |
| Return On Assets | 0.05 |
| Return On Equity | 0.07 |
| Revenue | 3.44B |
| Revenue/Share | 7.45 |
| Gross Profit | 1.71B |
| EBITDA | 466.28M |
| Net Income | 421.25M |
| Diluted EPS | 0.93 |
| Total Cash | 3.2B |
| Total Cash/Share | 7.07 |
| Total Debt | 222.65M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 4.65 |
| Book Value Per Share | 14.05 |
| 52-Week Change | -6.54 |
| 52-Week High | 35.2 |
| 52-Week Low | 12.58 |
| Moving Average 50 Days | 14.75 |
| Moving Average 200 Days | 17.75 |
| Average Volume | 7.59M |
| Shares Outstanding | 452.75M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.35 |
| Trailing Annual Dividend Yield | 2.65 |
| Payout Ratio | 0.7 |
| Last Split Factor | N/A |
| Last Split Date | N/A |